加拿大政府宣布,加速基于干细胞的1型糖尿病疗法

2020-11-30 Allan MedSci原创

有300,000多名加拿大人患有1型糖尿病(T1D),这是一种自身免疫性疾病,没有已知的病因或治愈方法,会导致在患者体内产生胰岛素的胰岛β细胞功能障碍、损害或丢失。

有300,000多名加拿大人患有1型糖尿病(T1D),这是一种自身免疫性疾病,没有已知的病因或治愈方法,会导致在患者体内产生胰岛素的胰岛β细胞功能障碍、损害或丢失。患有T1D的人必须每天多次使用胰岛素以保持血糖水平正常,尽管尽了最大的努力,但他们经常会遇到严重甚至危及生命的并发症。

加拿大卫生研究院(CIHR)宣布投资600万加元击败糖尿病,进行两项基于干细胞的T1D疗法。

干细胞来源胰腺β细胞的显示出巨大的希望,可以将其移植以提供新的胰岛素来源,以替代功能异常、受损或丢失的胰腺β细胞。2000年,加拿大埃德蒙顿的一个研究小组率先移植了胰岛,这种治疗将使患有T1D的人无需每天注射胰岛素就能过上健康的生活。

研究团队由多伦多大学的Maria Cristina Nostro博士以及不列颠哥伦比亚大学的Francis Lynn博士领导。他们将与其他加拿大研究人员合作,解决一些重大的科学挑战。

 

原始出处:

https://www.firstwordpharma.com/node/1778521

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1069547, encodeId=8931106954eff, content=已拜读,受益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Fri Nov 12 10:39:02 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921962, encodeId=9326921962e8, content=有魄力, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210131/b35591bafe2a4b869917b577adba9fab/c267322e38334bd6a95a8340ea85f70c.jpg, createdBy=f36b1426385, createdName=6322400001, createdTime=Mon Feb 01 15:42:19 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1025530, encodeId=68b21025530cd, content=干细胞是热点,但是进入临床仍然需要时间和临床疗效验证哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=独孤立克, createdTime=Thu Dec 03 19:51:01 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312660, encodeId=a79f1312660a3, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33006, encryptionId=1aa333006b4, topicName=加拿大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Wed Dec 02 10:51:01 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043410, encodeId=019010434105b, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Mon Nov 30 22:51:01 CST 2020, time=2020-11-30, status=1, ipAttribution=)]
    2021-11-12 湘雅科教

    已拜读,受益匪浅。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1069547, encodeId=8931106954eff, content=已拜读,受益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Fri Nov 12 10:39:02 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921962, encodeId=9326921962e8, content=有魄力, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210131/b35591bafe2a4b869917b577adba9fab/c267322e38334bd6a95a8340ea85f70c.jpg, createdBy=f36b1426385, createdName=6322400001, createdTime=Mon Feb 01 15:42:19 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1025530, encodeId=68b21025530cd, content=干细胞是热点,但是进入临床仍然需要时间和临床疗效验证哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=独孤立克, createdTime=Thu Dec 03 19:51:01 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312660, encodeId=a79f1312660a3, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33006, encryptionId=1aa333006b4, topicName=加拿大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Wed Dec 02 10:51:01 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043410, encodeId=019010434105b, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Mon Nov 30 22:51:01 CST 2020, time=2020-11-30, status=1, ipAttribution=)]
    2021-02-01 6322400001

    有魄力

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1069547, encodeId=8931106954eff, content=已拜读,受益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Fri Nov 12 10:39:02 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921962, encodeId=9326921962e8, content=有魄力, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210131/b35591bafe2a4b869917b577adba9fab/c267322e38334bd6a95a8340ea85f70c.jpg, createdBy=f36b1426385, createdName=6322400001, createdTime=Mon Feb 01 15:42:19 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1025530, encodeId=68b21025530cd, content=干细胞是热点,但是进入临床仍然需要时间和临床疗效验证哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=独孤立克, createdTime=Thu Dec 03 19:51:01 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312660, encodeId=a79f1312660a3, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33006, encryptionId=1aa333006b4, topicName=加拿大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Wed Dec 02 10:51:01 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043410, encodeId=019010434105b, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Mon Nov 30 22:51:01 CST 2020, time=2020-11-30, status=1, ipAttribution=)]
    2020-12-03 独孤立克

    干细胞是热点,但是进入临床仍然需要时间和临床疗效验证哦

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1069547, encodeId=8931106954eff, content=已拜读,受益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Fri Nov 12 10:39:02 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921962, encodeId=9326921962e8, content=有魄力, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210131/b35591bafe2a4b869917b577adba9fab/c267322e38334bd6a95a8340ea85f70c.jpg, createdBy=f36b1426385, createdName=6322400001, createdTime=Mon Feb 01 15:42:19 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1025530, encodeId=68b21025530cd, content=干细胞是热点,但是进入临床仍然需要时间和临床疗效验证哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=独孤立克, createdTime=Thu Dec 03 19:51:01 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312660, encodeId=a79f1312660a3, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33006, encryptionId=1aa333006b4, topicName=加拿大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Wed Dec 02 10:51:01 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043410, encodeId=019010434105b, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Mon Nov 30 22:51:01 CST 2020, time=2020-11-30, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1069547, encodeId=8931106954eff, content=已拜读,受益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Fri Nov 12 10:39:02 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921962, encodeId=9326921962e8, content=有魄力, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210131/b35591bafe2a4b869917b577adba9fab/c267322e38334bd6a95a8340ea85f70c.jpg, createdBy=f36b1426385, createdName=6322400001, createdTime=Mon Feb 01 15:42:19 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1025530, encodeId=68b21025530cd, content=干细胞是热点,但是进入临床仍然需要时间和临床疗效验证哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=独孤立克, createdTime=Thu Dec 03 19:51:01 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312660, encodeId=a79f1312660a3, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33006, encryptionId=1aa333006b4, topicName=加拿大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Wed Dec 02 10:51:01 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1043410, encodeId=019010434105b, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Mon Nov 30 22:51:01 CST 2020, time=2020-11-30, status=1, ipAttribution=)]
    2020-11-30 misszhang

    谢谢MedSci提供最新的资讯

    0

相关资讯

Nat Metab:干细胞+鱼油——治疗抑郁症的新武器

导言:简单地吃几片药到底能不能有效地缓解抑郁症症状?近年来,有研究证实干细胞可以一定程度改善和修复神经系统的结构和功能,也为利用干细胞治疗抑郁症提供了理论依据。另外,由于鱼肉中富含欧米伽-3脂肪酸,大

Protein & Cell:中科院发现,SIRT7作为异染色质稳定剂,拮抗人类干细胞衰老。

SIRT7作为与衰老和疾病有关的sirtuin家族成员,是新陈代谢和压力反应的调节器。至今为止,我们仍然不清楚人类成体干细胞群体如何受到SIRT7的影响。

Cell:揭秘鸡皮疙瘩与“防秃头”之间有着强大联系...

近日,发表在《Cell》上的一项研究中,来自美国哈佛大学的科学家们给了我们一些惊人的线索:引起鸡皮疙瘩的细胞类型对于调节再生毛囊和头发的干细胞也是非常重要的。简而言之,鸡皮疙瘩与“防秃头”之间有着联系

Biosci Rep:SDF-1和bFGF联合促进骨髓干细胞介导的牙周韧带再生

据报道,基质细胞衍生因子-1(SDF-1)和碱性成纤维细胞生长因子(bFGF)可诱导骨髓干细胞(BMSCs)分化为具有牙周韧带成纤维细胞特征的细胞。因此SDF-1和bFGF可能在BMSCs介导的牙周韧

DCR:脂肪干细胞可减少缺血性结直肠吻合术中的吻合口瘘的发生

结直肠切除吻合术后,吻合口漏(AL)仍然是最严重的术后并发症,发生率从1%到19%不等。

Transplantation:肝源间充质干细胞在小儿肝脏代谢性疾病中的I/II期试验

使用干细胞技术的再生医学是一个新兴的领域,目前正在对先天性和后天性肝病进行测试。

拓展阅读

Nature Medicine:从自动胰岛素输送到全功能人造胰腺:1型糖尿病治疗的突破

全自动人造胰腺的研究和试验正在全球范围内积极进行中,许多研究已经展示了这些系统在提高血糖控制、减少低血糖事件以及改善患者生活质量方面的巨大潜力。

Cardiovasc Diabetol:脂肪肝指数是1型糖尿病患者全因死亡率和主要心血管事件的独立危险因素

这项观察性前瞻性研究表明,脂肪肝指数与1型糖尿病患者更高的全因死亡率和心血管事件发生率增加有关。

JAMA子刊:1型糖尿病儿童患者住院期间,使用家庭胰岛素泵安全吗?

在儿童医院使用家庭胰岛素泵在防治高血糖和低血糖方面是安全的。这些数据支持在不需要重症监护且没有活动性DKA的患者中,在儿科住院期间使用家庭胰岛素泵。

Int J Ophthalmol:应用OCTA定量检测无临床视网膜病变的1型糖尿病患儿乳头周围血管密度和视网膜神经纤维层

近年来,1型糖尿病(T1DM)的发病率呈上升趋势。T1DM进展快,并发症出现早,给家庭和社会造成沉重的经济负担。

Front Endocrinol:强化治疗的1型糖尿病患者龈沟液微生物组与代谢组之间的相互作用

糖尿病不仅会影响口腔微生物群,还会增加口腔多发局部异常的风险,影响糖尿病患者的生活质量。糖尿病患者极易患龋齿、牙齿脱落和牙周病(PD)。

Lancet Diabetes Endocrinol:1型糖尿病中胰岛素C肽与代谢改善的关联

在1型糖尿病新发病例中,保持β细胞功能的干预能显著改善代谢结果,其中C肽保留与HbA1c改善直接成比例,支持C肽作为治疗效果的替代指标。